gdc
Liver Cancer

Drugs for Liver Cancer

Here are the financial support services available to patients receiving treatment for Liver Cancer.

Defitelio (defibrotide sodium)

Drug company: Jazz Pharmaceuticals
888-837-4397

Defitelio is used for the treatment of adult and pediatric patients with hepatic veno-occlusive disease, a rare and life-threatening liver condition that can occur after hematopoietic stem-cell transplantation in patients with different types of cancers.

Jazz Pharmaceuticals offers 1 financial assistance program for patients using Defitelio:

JumpStart Patient Assistance Program

For patients who meet the program’s requirements, the JumpStart Patient Assistance Program offers Defitelio free of charge.

Nexavar (sorafenib) Tablets

Drug company: Bayer
866-639-2827

Nexavar is a kinase inhibitor used for the treatment of patients with unresectable hepatocellular carcinoma (liver cancer).

Bayer offers 2 financial assistance programs for patients using Nexavar:

Nexavar $0 Co-Pay Program

With this program, patients with private insurance pay $0 copay for Nexavar, and the program pays up to $25,000 per patient annually.

REACH Patient Assistance Program

Uninsured or underinsured patients who are prescribed Nexavar should contact the Resources for Expert Assistance and Care Helpline (REACH) services counselor to possibly qualify for free medication for up to 12 months.

Opdivo (nivolumab)

Drug company: Bristol-Myers Squibb
800-861-0048

Opdivo is a PD-1 inhibitor used for the treatment of patients with hepatocellular carcinoma (liver cancer) who have previously received sorafenib.

Bristol-Myers Squibb (BMS) Access Support offers 2 financial assistance programs for patients using Opdivo:

BMS Oncology Co-Pay Assistance Program

This program provides financial assistance with out-of-pocket deductibles, copay, or coinsurance costs for eligible patients with private insurance who have been prescribed Opdivo. Patients pay $25 copay, while BMS covers the remaining amount, up to $25,000 annually per medication.

Bristol-Myers Squibb Patient Assistance Foundation

Patients who don’t have public or private insurance that helps to pay for Opdivo, may be eligible for help paying for their prescription medication if they receive treatment as an outpatient and have an annual income of less than 300% of the federal poverty level, up to $35,640 for an individual or $48,060 for a family of 2.

Stivarga (regorafenib) Tablets

Drug company: Bayer
866-639-2827

Stivarga is a kinase inhibitor used for the treatment of patients with hepatocellular carcinoma (liver cancer) who have received sorafenib.

Bayer offers 2 financial assistance programs for patients using Stivarga:

STIVARGA $0 Co-Pay Program

Through this program, patients with private insurance will have a $0 copay for Stivarga, up to $25,000 per patient annually.

REACH Patient Assistance Program

Uninsured or underinsured patients who are prescribed Stivarga should contact the Resources for Expert Assistance and Care Helpline (REACH) services counselor to possibly qualify for free medication.

Table. Drugs Prescribed for Liver Cancer

  • Drug name (generic name)
  • Drug company
  • Indication
  • Patient support services
    Drug name (generic name)
  • Defitelio (defibrotide sodium)
  • Drug company
  • Jazz Pharmaceuticals
  • Indication
  • Hepatic veno-occlusive disease (often associated with cancer-related transplant)
  • Patient support services
  • JumpStart Patient Assistance Program
    888-837-4387




Last modified: April 16, 2018

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country